Plasma endothelin levels and surgically correctable pulmonary hypertension

Area of Science:

• Cardiology
• Pulmonology
• Endocrinology

Background:

• Pulmonary hypertension is a serious condition affecting the arteries in the lungs and heart.
• Endothelins are peptides with potent vasoconstrictive properties.
• The specific role of endothelin isoforms in valvular heart disease-associated pulmonary hypertension requires further elucidation.

Purpose of the Study:

• To investigate the changes in plasma endothelin-1 and endothelin-3 concentrations in patients with pulmonary hypertension secondary to valvular heart disease.
• To determine the correlation between plasma endothelin levels and hemodynamic parameters indicative of pulmonary hypertension severity.
• To assess the impact of surgical correction of valvular lesions on plasma endothelin levels and pulmonary arterial pressures.

Main Methods:

• A cohort of 32 patients with valvular heart disease was studied, divided into two groups: 22 with pulmonary hypertension (group I) and 10 with normal pulmonary arterial pressures (group II).
• Plasma concentrations of endothelin-1 and endothelin-3 were measured.
• Hemodynamic parameters including cardiac output, pulmonary capillary wedge pressure, mean pulmonary arterial pressure, and pulmonary vascular resistance were assessed.
• Patients in group I underwent surgical correction of valvular lesions, and plasma endothelin levels were re-evaluated postoperatively.

Main Results:

• Plasma endothelin-1 concentrations were significantly higher in patients with pulmonary hypertension (group I) compared to those without (group II) (p < 0.05).
• Plasma endothelin-1 levels showed a significant positive linear correlation with cardiac output and pulmonary capillary wedge pressure, and correlated significantly with mean pulmonary arterial pressure and pulmonary vascular resistance.
• Following surgical correction, patients in group I exhibited a significant decrease in pulmonary arterial pressures and plasma endothelin-1 levels (from 3.84 +/- 0.20 pg/mL to 1.66 +/- 0.07 pg/mL, p < 0.05).
• Plasma endothelin-3 concentrations did not differ significantly between groups or change substantially after surgery.

Conclusions:

• Plasma endothelin-1, but not endothelin-3, plays a significant role in the pathophysiology of pulmonary hypertension associated with valvular heart disease.
• Endothelin-1 appears to function as a reactive mediator contributing to vasoconstriction in pulmonary hypertension rather than as a primary trigger.
• These findings highlight endothelin-1 as a potential therapeutic target in managing pulmonary hypertension in this patient population.